News

MorphoSys receives a license under the Kauffman patent estate to generate and screen certain recombinant peptide and protein libraries and to commercialize any resulting products.

Illumina will use Sentrix® Arrays in conjunction with the Company's GoldenGate® and Infinium™ assays to conduct genetic studies for thousands of samples provided by GSK.

A 2½ day workshop hosted by BioDot, Amic, Active Motif and Blueshift Biotechnologies on.

The Chemical Synthesis Scale-up Division will be charged with developing systems to produce multi-kilogram to manufacturing scale quantities of synthesized materials.

The scientists at Boston Biomedical combined the power of several techniques including X-ray crystallography, resonance energy transfer and molecular modeling to obtain a three-dimensional, atomic resolution structure of the neck region of myosin V.

Invitrogen will combine its Voltage Sensor Probes ion channel reagents with PerkinElmer’s CellLux™ Fluorescence Cellular Screening Platform.

This patent family, owned by Alnylam, covers small interfering RNAs and their use to mediate RNAi in mammalian cells.

GenomeQuest™ is a genomic information service and software application that provides sequence comparison solutions for biological and patent investigators.

ULS™ is now the preferred labeling method for both bacterial gene expression profiling and Chip on Chip assays that have been developed at the ISB.

Sequenom's iPLEX assay is very useful for evaluating targeted sets of SNPs and also expedites follow up work in the validation of genome scan results.